Medtronic (MDT) to report Q4 2026 results on 6/3, expected revenue of $9.61B & EPS of $1.55. Recent acquisition of SPR Therapeutics adds to neuromodulation business. Analyst ratings show mixed opinions.
Medtronic PLC (NYSE:MDT) is set to report its fiscal fourth quarter 2026 results before the opening bell on Wednesday, June 3.
Analysts expect the Minneapolis, Minnesota-based company to post revenue of $9.61 billion, up 7.6% from the year-ago quarte… [1707 chars]
Source: Benzinga | Published: 2026-06-03T07:54:13Z
Credit: Benzinga
